✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (234 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
165
4,33,620
71.57
1,54,837
28.92
1,12,194
31.22
1,11,123
33.02
1,06,328
16.47
1,04,830
48.23
98,270
35.08
84,710
1,823
67,843
28.98
63,322
-
61,328
35.97
55,826
35.52
40,232
41.29
39,097
51.18
36,309
34.68
35,926
44.88
32,892
99.18
31,441
113
21,406
28.56
20,632
109
20,610
79.65
19,440
47.38
18,984
872
18,497
46.22
18,329
46.19
15,520
12.07
15,472
22.81
14,607
53.80
14,163
58.12
12,315
38.00
11,427
143
10,920
80.34
10,683
41.34
10,661
169
10,597
57.19
10,571
31.86
10,414
87.83
9,805
17.47
9,718
78.69
8,465
4.67
7,250
23.19
7,185
-
7,084
22.09
6,315
293
5,947
38.21
5,385
102
4,651
47.96
4,646
152
4,243
90.49
4,224
31.42
4,141
28.61
3,941
58.96
3,723
31.73
3,654
41.10
3,600
17.46
3,403
-
3,291
19.76
3,141
41.61
2,749
38.47
2,591
175
2,506
24.24
2,408
-
2,298
17.97
2,238
47.33
1,964
45.46
1,893
60.15
1,834
25.51
1,694
32.01
1,668
27.84
1,612
33.29
1,417
32.21
1,388
17.67
1,343
59.76
1,318
39.05
1,274
14.47
1,272
19.31
1,268
75.62
1,242
42.23
1,188
25.13
1,102
47.90
1,021
15.51
997
-
960
14.50
959
57.30
918
28.80
876
39.08
859
28.06
821
28.82
802
19.32
793
43.40
771
20.33
659
103
605
39.59
589
26.84
551
29.92
544
15.09
524
25.75
518
21.49
460
-
415
23.68
410
35.43
393
68.34
379
80.22
371
27.14
356
69.79
346
32.28
311
33.67
305
15.58
297
-
269
15.95
257
56.73
256
14.72
254
-
251
13.95
248
44.63
248
21.47
232
-
229
-
226
56.38
224
746
222
19.05
208
33.69
196
37.14
188
26.15
181
-
180
13.69
178
10.68
175
96.05
174
660
171
17.27
169
11.03
166
46.56
165
33.46
165
-
161
21.52
160
14.44
156
7.83
154
15.78
153
29.55
149
12.69
149
9.81
147
35.44
141
-
138
20.45
138
22.69
138
38.68
132
18.74
130
21.27
123
29.89
122
66.70
121
25.85
106
-
102
98.22
102
12.04
101
19.24
93
23.10
93
-
93
13.08
91
7.33
84
19.10
75
-
73
4.07
72
37.16
72
-
71
18.24
70
20.10
68
-
64
40.31
63
-
62
21.15
59
11.29
56
-
53
-
52
17.14
52
110
50
91.19
50
11.64
49
5.45
49
20.60
48
-
46
-
45
10.85
45
-
44
99.65
44
20.47
41
25.90
40
-
40
448
37
-
36
46.46
34
10.87
33
-
32
14.13
32
4.87
31
-
28
7.92
27
31.19
27
4.28
26
11.58
25
-
24
-
24
18.30
23
93.79
23
-
23
-
22
11.09
22
28.89
22
-
21
35.42
20
152
18
3,374
17
-
16
-
15
26.85
14
-
14
-
14
166
13
-
13
28.78
13
8.03
13
27.47
12
12.52
9
-
8
-
8
89.06
8
-
8
89.76
7
-
7
-
5
69.81
4
-
4
-
3
-
2
Showing 5 234 of 234 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material